Subscribe to RSS - Part B infusion drugs

Part B infusion drugs

Deadline to sign infusion letter looms

 - 
01/19/2017

WASHINGTON – The National Home Infusion Association seeks signatures for a letter that urges Congress to align the effective dates of switching to an average sales price reimbursement model for Part B infusion drugs and initiating payments for infusion services.

Cures Act imposes ASP model for infusion drugs

In bad-good scenario, bill will also finally pave way to reimbursement for services
 - 
12/09/2016

WASHINGTON – While the broader HME industry is cheering the passage of the 21st Century Cures Act, home infusion is facing reimbursement cuts—effective almost immediately.